Related references
Note: Only part of the references are listed.Molecular Causes for BUBR1 Dysfunction in the Human Cancer Predisposition Syndrome Mosaic Variegated Aneuploidy
Saskia J. E. Suijkerbuijk et al.
CANCER RESEARCH (2010)
Antitumor activity of an allosteric inhibitor of centromere-associated protein-E
Kenneth W. Wood et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)
Small Molecule Aurora Kinases Inhibitors
Laura Garuti et al.
CURRENT MEDICINAL CHEMISTRY (2009)
Initial Testing (Stage 1) of the Kinesin Spindle Protein Inhibitor Ispinesib by the Pediatric Preclinical Testing Program
Hernan Carol et al.
PEDIATRIC BLOOD & CANCER (2009)
Aurora kinases as anticancer drug targets
Oliver Gautschi et al.
CLINICAL CANCER RESEARCH (2008)
A phase II and pharmacokinetic study of SB-715992, in patients with metastatic hepatocellular carcinoma: A study of the National Cancer Institute of Canada Clinical Trials Group (NCIC CTG IND.168)
Jennifer J. Knox et al.
INVESTIGATIONAL NEW DRUGS (2008)
Initial testing (stage 1) of the proteasome inhibitor bortezomib by the pediatric preclinical testing program
Peter J. Houghton et al.
PEDIATRIC BLOOD & CANCER (2008)
A phase II study of ispinesib (SB-715992) in patients with metastatic or recurrent malignant melanoma:: a National Cancer Institute of Canada Clinical Trials Group trial
Christopher W. Lee et al.
INVESTIGATIONAL NEW DRUGS (2008)
The pediatric preclinical testing program: Description of models and early testing results
Peter J. Houghton et al.
PEDIATRIC BLOOD & CANCER (2007)
A fluorescence microplate cytotoxicity assay with a 4-log dynamic range that identifies synergistic drug combinations
Tomas Frgala et al.
MOLECULAR CANCER THERAPEUTICS (2007)
Targeted anti-mitotic therapies: can we improve on tubulin agents?
Jeffrey R. Jackson et al.
NATURE REVIEWS CANCER (2007)
Potentiation of kinesin spindle protein inhibitor-induced cell death by modulation of mitochondrial and death receptor apoptotic pathways
Ulka Vijapurkar et al.
CANCER RESEARCH (2007)
Aneuploidy acts both oncogenically and as a tumor suppressor
Beth A. A. Weaver et al.
CANCER CELL (2007)
Tubulin-associated drug targets: Aurora kinases, polo-like kinases, and others
Steven L. Warner et al.
SEMINARS IN ONCOLOGY (2006)
Evaluation of the antitumor efficacy, pharmacokinetics, and pharmacodynamics of the histone deacetylase inhibitor depsipeptide in childhood cancer models in vivo
C Graham et al.
CLINICAL CANCER RESEARCH (2006)
In vivo evaluation of ixabepilone (BMS247550), a novel epothilone B derivative, against pediatric cancer models
JK Peterson et al.
CLINICAL CANCER RESEARCH (2005)
Microtubule capture by CENP-E silences BubR1-dependent mitotic checkpoint signaling
YH Mao et al.
JOURNAL OF CELL BIOLOGY (2005)
Monastrol, a prototype anti-cancer drug that inhibits a mitotic kinesin, induces rapid bursts of axonal outgrowth from cultured postmitotic neurons
SA Haque et al.
CELL MOTILITY AND THE CYTOSKELETON (2004)
Stuck in division or passing through: What happens when cells cannot satisfy the spindle assembly checkpoint
CL Rieder et al.
DEVELOPMENTAL CELL (2004)
Constitutional aneuploidy and cancer predisposition caused by biallelic mutations in BUB1B
S Hanks et al.
NATURE GENETICS (2004)
Characterization of childhood acute lymphoblastic leukemia xenograft models for the preclinical evaluation of new therapies
NLM Liem et al.
BLOOD (2004)
CENP-E forms a link between attachment of spindle microtubules to kinetochores and the mitotic checkpoint
XB Yao et al.
NATURE CELL BIOLOGY (2000)
Share Paper
